ASCO 2025: vídeos e entrevistas

85 vídeos do ASCO 2025 publicados por ASCO, ASCO Podcasts, OncLive, Oncology Brothers, Targeted Oncology, ecancer. Atualizado em 20/11/2026.

Ver no OncoTV com filtros

Managing Immune-Related Toxicities in OncologyASCO Podcasts · 06/11/2025 · 14:59A Podcast About Podcasts: Podcasts as Educational Tools for Providers (and Patients)ASCO Podcasts · 21/10/2025 · 23:15IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)Oncology Brothers · 06/10/2025 · 25:31 · apoio da indústriaManaging Side Effects of New Treatments for Small Cell Lung CancerOncology Brothers · 29/08/2025 · 14:57 · apoio da indústriaKey insights from lung cancer research at ASCO 2025ecancer · 28/08/2025 · 15:32 · apoio da indústriaKey insights from head and neck research at ASCO 2025ecancer · 28/08/2025 · 14:20 · apoio da indústriaCatequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcomaecancer · 28/08/2025 · 3:01 · apoio da indústriaAI improves accuracy in identifying HER2-low and HER2-ultralow breast cancersecancer · 28/08/2025 · 5:54 · apoio da indústriaPrimary cytoreductive surgery shows PFS benefit in advanced ovarian cancerecancer · 28/08/2025 · 3:58 · apoio da indústriaHPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCCecancer · 28/08/2025 · 2:38 · apoio da indústriactDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancerecancer · 28/08/2025 · 5:26 · apoio da indústriaASCO 2025: Breast cancer treatment highlightsecancer · 28/08/2025 · 4:36 · apoio da indústriaQoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBCecancer · 28/08/2025 · 5:39 · apoio da indústriaLong-term infusion of dinutuximab beta improves survival in high-risk neuroblastomaecancer · 28/08/2025 · 6:27 · apoio da indústriaUpfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRCecancer · 28/08/2025 · 2:15 · apoio da indústriaRopeginterferon Alfa-2b shows superior efficacy and safety over anagrelide in essential thromboc...ecancer · 28/08/2025 · 3:56 · apoio da indústriaNivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible metastatic urotheli...ecancer · 28/08/2025 · 4:01 · apoio da indústriaMolecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapyecancer · 28/08/2025 · 2:56 · apoio da indústriaRusfertide shows promise for polycythemia vera treatmentecancer · 28/08/2025 · 4:05 · apoio da indústriaGLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabeticsecancer · 28/08/2025 · 2:41 · apoio da indústriaOS benefit for Tumor Treating Fields plus chemo in unresectable pancreatic cancerecancer · 28/08/2025 · 3:27 · apoio da indústriaEncorafenib/binimetinib/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastasesecancer · 28/08/2025 · 3:46 · apoio da indústriaHER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testingecancer · 28/08/2025 · 7:05 · apoio da indústriaTrastuzumab deruxtecan benefit for some advanced gastric cancersecancer · 28/08/2025 · 3:23 · apoio da indústriaQoL improvements ID'd in phase 3 ARANOTE trial for mHSPCecancer · 28/08/2025 · 3:39 · apoio da indústriaTrastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced b...ecancer · 28/08/2025 · 2:36 · apoio da indústriaSacituzumab govitecan helps some patients with PD-L1 triple-negative breast cancer live longer w...ecancer · 28/08/2025 · 1:50 · apoio da indústriaASCO 2025: Update on blood-based cancer assaysecancer · 28/08/2025 · 3:32 · apoio da indústriaEcological evaluation of climate risks for cancer survivorsecancer · 28/08/2025 · 3:14 · apoio da indústriaEnhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resect...ecancer · 28/08/2025 · 3:31 · apoio da indústriaStudy shows characteristics associated with longer-term overall survival with NALIRIFOX regimen ...ecancer · 28/08/2025 · 2:29 · apoio da indústriaNeoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancerecancer · 28/08/2025 · 3:50 · apoio da indústriaCemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinomaecancer · 28/08/2025 · 4:27 · apoio da indústriaRelacorilant plus chemo improves PFS and OS vs chemo alone in platinum-resistant ovarian cancerecancer · 28/08/2025 · 3:32 · apoio da indústriaPerioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancersecancer · 28/08/2025 · 5:52 · apoio da indústriaAbemaciclib potential therapeutic option for Kaposi sarcomaecancer · 28/08/2025 · 5:33 · apoio da indústriaBCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBCecancer · 28/08/2025 · 4:07 · apoio da indústriaPro-inflammatory diets associated with worse outcomes for stage III colon cancerecancer · 28/08/2025 · 2:30 · apoio da indústriaBarriers to global oncology clinical trial participation in sub-Saharan Africaecancer · 28/08/2025 · 4:52 · apoio da indústriaMaking immune check point inhibitors for lung cancer cost-effective in LMICsecancer · 28/08/2025 · 5:37 · apoio da indústriaSocial determinants and survival outcomes in early-onset colorectal cancer in the USecancer · 28/08/2025 · 5:49 · apoio da indústriaOral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBCecancer · 28/08/2025 · 4:39 · apoio da indústriaLow frequency of actionable dihydropyrimidine dehydrogenase variants in Mexicans with GI cancers...ecancer · 28/08/2025 · 3:30 · apoio da indústriaCtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative du...ecancer · 28/08/2025 · 4:19 · apoio da indústriaExercise programme may lower risk of recurrence and death for some colon cancer survivorsecancer · 28/08/2025 · 4:05 · apoio da indústriaUntangling ASCO 2025 Data in Oncology: Episode 4OncLive · 23/07/2025 · 7:16 · apoio da indústriaUntangling ASCO 2025 Data in Oncology: Episode 3OncLive · 16/07/2025 · 5:54 · apoio da indústriaUntangling ASCO 2025 Data in Oncology: Episode 2OncLive · 09/07/2025 · 9:09 · apoio da indústriaASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARAOncology Brothers · 04/07/2025 · 18:17 · apoio da indústriaUntangling ASCO 2025 Data in Oncology: Episode 1OncLive · 02/07/2025 · 6:12 · apoio da indústriaImmunotherapy at ASCO25: Drug Development, Melanoma Treatment, and MoreASCO Podcasts · 27/06/2025 · 27:02Innovations in GU Cancer Treatment at ASCO25ASCO Podcasts · 26/06/2025 · 29:47Dr Turk Delves Into CRC Updates From ASCO 2025Targeted Oncology · 26/06/2025 · 4:35 · apoio da indústriaWhat Lung Cancer Abstracts Stood Out at ASCO25?ASCO Podcasts · 25/06/2025 · 29:50GI Cancer Research at ASCO25: Plenary Highlights and MoreASCO Podcasts · 24/06/2025 · 21:17Breast Cancer Research Poised to Change Practice From ASCO25ASCO Podcasts · 23/06/2025 · 31:39Precision Oncology Advances in Hematologic Cancers at ASCO25ASCO Podcasts · 20/06/2025 · 18:23ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04Oncology Brothers · 20/06/2025 · 22:29 · apoio da indústriaASCO25 Recap: CHALLENGE, DESTINY-Breast09, and MoreASCO Podcasts · 19/06/2025 · 25:46ASCO 2025: Expert Insights & Top Abstracts Across CancersTargeted Oncology · 19/06/2025 · 9:37 · apoio da indústria